Valuation: Stille AB

Market Cap 216.55Cr 22Cr 20Cr 18Cr 17Cr 31Cr 2.16TCr 32Cr 85Cr 1.06TCr 84Cr 83Cr 3.65TCr P/E 2026 *
24.4x
P/E 2027 * 20.1x
Enterprise Value 207.85Cr 22Cr 19Cr 17Cr 16Cr 30Cr 2.08TCr 31Cr 82Cr 1.02TCr 81Cr 79Cr 3.5TCr EV / Sales 2026 *
2.93x
EV / Sales 2027 * 2.53x
Free-Float
53.19%
Yield 2026 *
-
Yield 2027 * 0.83%
Manager TitleAgeSince
Chief Executive Officer 48 12/05/2025
Director of Finance/CFO 54 08/12/2025
Chief Operating Officer - 02/01/2026
Director TitleAgeSince
Director/Board Member 66 01/01/2000
Director/Board Member 63 01/01/2021
Director/Board Member 62 01/01/2023
Change 5-day change 1-year change 3-year change Capi.($)
-3.75%-8.33% - - 23Cr
+2.13%+5.44%-30.21%-46.86% 1.43TCr
-3.99%-6.87%+44.19%+91.25% 426.66Cr
+2.50%-2.94%+302.09%+198.63% 321.8Cr
-2.64%+8.02%-24.04%-27.22% 263.92Cr
-1.42%+5.78%-46.38%-66.92% 203.22Cr
-1.69%+8.41%-23.08%-20.18% 202.34Cr
-0.76%-0.76%-2.96%-29.19% 129.94Cr
-1.16%0.00%+25.74%+36.80% 99Cr
-0.97%+5.65%-7.56%-10.97% 99Cr
Average -1.18%+3.64%+26.42%+13.93% 352.53Cr
Weighted average by Cap. +0.13%+2.86%+17.01%+3.12%

Financials

2026 *2027 *
Net sales 71Cr 7.36Cr 6.43Cr 5.94Cr 5.47Cr 10Cr 709.02Cr 11Cr 28Cr 347.25Cr 28Cr 27Cr 1.2TCr 78Cr 8.1Cr 7.08Cr 6.54Cr 6.02Cr 11Cr 780.41Cr 12Cr 31Cr 382.21Cr 30Cr 30Cr 1.32TCr
Net income 9.42Cr 97.78L 85.45L 78.85L 72.68L 1.37Cr 94Cr 1.4Cr 3.71Cr 46Cr 3.67Cr 3.59Cr 158.76Cr 11Cr 1.12Cr 97.92L 90.36L 83.29L 1.57Cr 107.9Cr 1.6Cr 4.25Cr 53Cr 4.21Cr 4.12Cr 181.93Cr
Net Debt -8.7Cr -90.26L -78.88L -72.79L -67.09L -1.26Cr -87Cr -1.29Cr -3.42Cr -43Cr -3.39Cr -3.32Cr -146.55Cr -19Cr -1.93Cr -1.69Cr -1.56Cr -1.43Cr -2.7Cr -185.84Cr -2.76Cr -7.32Cr -91Cr -7.25Cr -7.09Cr -313.32Cr
Logo Stille AB
Stille AB is a Sweden-based company engaged in the development, manufacture, and marketing of technical medical equipment. The product portfolio is divided into two business lines. The Surgery business area develops, produces and markets handcrafted, forged surgical instruments for all fields of open surgery, with an emphasis on cardiovascular surgery, and reconstructive and aesthetic plastic surgery. Its products include scissors, forceps, artery forceps, needle holders and clamps, among others. The Patient Positioning area develops and manufactures two main groups of procedure-specific specialized tables for cardiovascular surgery and gynecology, urology and urodynamic examinations. As of December 31, 2011, the Company had two wholly owned subsidiaries, Stille Surgical Inc. and Stille Incentive AB. As of December 30, 2011, the it's largest shareholder was Linc Invest AB (39.81%). On September 2, 2013, the Company sold its business unit, Sonesta, to ADDvise Lab Solutions publ AB.
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
-